Loading...
Loading...
Also known as: Spadin derivative, TREK-1 antagonist
Synthetic nootropic peptide that enhances cognition through TREK-1 potassium channel inhibition.
Benefits
6
Conditions
5
Evidence
Preclinical animal models of depression and cognition+ studies
Source
Synthetic TREK-1 channel antagonist
Gabriel Brain Score
Strong
Synthetic nootropic peptide that enhances cognition through TREK-1 potassium channel inhibition.
Potently blocks TREK-1 potassium channels (~100-fold more than spadin), increases neuronal excitability and synaptic transmission, upregulates BDNF expression, promotes hippocampal neurogenesis within 4 days, enhances serotonergic transmission.
* Dosing should be individualized. Always consult with a qualified healthcare practitioner.
Preclinical animal models of depression and cognition
Strong preclinical evidence for rapid antidepressant and cognitive effects. No human clinical trials. Faster onset than traditional antidepressants in animal models.
Potent cognitive enhancer that activates hepatocyte growth factor (HGF) pathway for synaptic plasticity.
Russian synthetic peptide derived from ACTH with potent nootropic and neuroprotective effects.
Synthetic analogs of cortexin bioregulatory peptides with optimized properties for cognitive and neuroprotective applications.